NASDAQ:LYEL | Income Statement | Lyell Immunopharma, Inc.

Complete source-backed income-statement history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$4,000.00$39.52M$47.34M-$47.34M$2.58M-$44.76M-$1.92-$1.9223,364,00023,364,000
2026-03-31$2,000.00$36.6M$44.26M-$44.26M$20.11M-$24.15M-$1.10-$1.1021,876,00021,876,000
2025-12-31$6,000.00$127.65M-$127.64M-$13.08M-$140.72M-$7.68-$7.681,141,0001,141,000
2025-09-30$15,000.00$28.17M$37.27M-$37.25M-$1.59M-$38.85M-$2.13-$2.1318,268,00018,268,000
2025-06-30$8,000.00$34.86M$47.15M-$47.14M$4.46M-$42.68M-$2.89-$2.8914,793,00014,793,000
2025-03-31$7,000.00$43.45M$57.37M-$57.37M$5.17M-$52.2M-$3.54-$3.5414,755,00014,755,000
2024-12-31$11,000.00$201.16M-$201.15M$9.21M-$191.94M-$14.40-$14.40308,000308,000
2024-09-30$34,000.00$39.5M$50.54M-$50.51M$5.92M-$44.58M-$3.48-$3.4812,815,00012,815,000
2024-06-30$13,000.00$40.26M$51.54M-$51.53M$5.72M-$45.81M-$3.59-$3.5912,770,00012,770,000
2024-03-31$3,000.00$43.17M$55.58M-$55.58M-$5.09M-$60.67M-$0.24-$0.24254,252,000254,252,000
2023-12-31$13,000.00$47M$59.52M-$59.51M$6.58M-$52.93M-$17.97-$17.97-237,828,000-237,828,000
2023-09-30$25,000.00$43.85M$59.06M-$59.04M$8.19M-$50.85M-$0.20-$0.20251,318,000251,318,000
2023-06-30$27,000.00$47.47M$65.93M-$65.91M$2.02M-$63.89M-$0.26-$0.26250,204,000250,204,000
2023-03-31$65,000.00$44.63M$62.62M-$62.56M-$4.4M-$66.96M-$0.27-$0.27249,591,000249,591,000
2022-12-31$48.39M$38.03M$63.17M-$14.78M$6.39M-$8.4M-$0.03-$0.03795,000795,000
2022-09-30$3,000.00$41.61M$66.44M-$66.44M-$3.82M-$70.25M-$0.28-$0.28248,320,000248,320,000
2022-06-30$35.74M$43.72M$73M-$37.26M$938,000.00-$36.32M-$0.15-$0.15246,312,000246,312,000
2022-03-31$553,000.00$35.83M$69.13M-$68.58M$432,000.00-$68.14M-$0.28-$0.28244,178,000244,178,000
2021-12-31$2.82M$19.29M$50.36M-$47.54M-$36.17M-$83.71M-$0.18-$0.1835,315,00035,315,000
2021-09-30$2.76M$31.43M$51.92M-$49.16M$286,000.00-$48.88M-$0.20-$0.20239,384,000239,384,000
2021-06-30$2.63M$46.45M$65.34M-$62.71M$112,000.00-$62.6M-$1.47-$1.4742,713,00042,713,000
2021-03-31$2.45M$41.53M$57.82M-$55.37M$327,000.00-$55.04M-$3.19-$3.1917,272,00017,272,000
2020-12-31$2.31M$35.09M$41.84M-$39.52M-$38.86M13,245,375
2020-09-30$1.07M$24.5M$37.91M-$36.84M-$35.72M13,893
2020-06-30$3.12M$97.15M$105.68M-$102.57M-$100.66M12,313

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$36,000.00$269.44M-$269.4M-$5.04M$0.00-$274.45M-$16.06-$16.0617,093,00017,093,000
2024-12-31$61,000.00$358.82M-$358.76M$15.76M-$342.99M-$26.23-$26.2313,074,00013,074,000
2023-12-31$130,000.00$182.95M$247.14M-$247.01M$12.38M-$234.63M-$18.70-$18.7012,549,00012,549,000
2022-12-31$84.68M$159.19M$271.74M-$187.06M$3.94M-$183.12M-$0.74-$0.74247,080,000247,080,000
2021-12-31$10.65M$138.69M$225.43M-$214.78M-$35.44M-$250.22M-$1.84-$1.84135,918,000135,918,000
2020-12-31$7.76M$182.24M$219.69M-$211.94M$7.47M-$204.47M-$15.69-$15.6913,258,00013,258,000
2019-12-31$657,000.00$63.6M$102.75M-$102.09M-$27.29M-$129.38M-$24.04-$24.045,4295,429